M
attos
FR
98
R
ev
A
ssoc
M
ed
B
ras
2015; 61(2):97-98
6. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH et
al. Exercise and physical activity in the prevention and treatment of
atherosclerotic cardiovascular disease: a statement from the Council on
Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention)
and the Council onNutrition, Physical Activity andMetabolism (Subcommittee
on Physical Activity). Circulation 2003;107:3109-16.
7. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA 3
rd
, et
al. Exercise and acute cardiovascular events placing the risks into perspective:
a scientific statement from the American Heart Association Council on
Nutrition, Physical Activity, and Metabolism and the Council on Clinical
Cardiology. Circulation 2007;115(17):2358–68.
8.
Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced
risk of cardiovascular events. Potential mediating mechanisms. Circulation
2007;116:2110–8.
9.
Smith JK. Exercise and cardiovascular disease. Cardiovasc Hematol Disord
Drug Targets. 2010;10(4):269-72.
10.
Möhlenkamp S, Lehmann N, Breuckmann F, Bröcker-Preuss M, Nassenstein
K, Halle M et al. Marathon Study Investigators; Heinz Nixdorf Recall Study
Investigators. Running: the risk of coronary events: Prevalence and prognostic
relevance of coronary atherosclerosis in marathon runners. Eur Heart J.
2008;29(15):1903-10.
11.
Schwartz JG, Merkel-Kraus S, Duval S, et al. “Does elite athleticism enhance
or inhibit coronary artery plaque formation?” American College of Cardiology
2010 Scientific Sessions; March 16, 2010; Atlanta, GA, USA.
12.
Kroger K, Lehmann N, Rappaport L, Perrey M, Sorokin A, Budde T et al.
Carotid and peripheral atherosclerosis in male marathon runners. Med Sci
Sports Exerc. 2011;43(7):1142-7.